Format

Send to

Choose Destination
Nature. 2019 Aug;572(7769):E18. doi: 10.1038/s41586-019-1459-x.

Publisher Correction: The metabolite BH4 controls T cell proliferation in autoimmunity and cancer.

Author information

1
IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
2
Department of Neurobiology, Harvard Medical School, Boston, MA, USA.
3
FM Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.
4
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Center, Vienna, Austria.
5
Département de Pharmacologie et Physiologie, Université de Montréal, Montréal, Québec, Canada.
6
Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
7
Department of Internal Medicine II (Infectious Diseases, Immunology, Rheumatology and Pneumology), Medical University of Innsbruck, Innsbruck, Austria.
8
Institute of Chemical Sciences and Engineering, Institute of Bioengineering, National Centre of Competence in Research (NCCR) in Chemical Biology, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
9
Division of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.
10
Wellcome Trust Centre for Human Genetics, Roosevelt Drive, University of Oxford, Oxford, UK.
11
Division of Gastroenterology and Liver Center, Department of Medicine, Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School (HMS), Harvard University, Boston, MA, USA.
12
LABOX, Departamento de Bioquímica, Universidade Federal de Santa Catarina, Florianópolis, Brazil.
13
Research Institute of Molecular Pathology, Vienna Biocenter, Campus-Vienna-Biocenter 1, Vienna, Austria.
14
Karolinska Institute, Department of Medicine Solna, Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.
15
Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany.
16
Department of Neurosciences, Centre de Recherche de CHU de Québec-Université Laval, Québec, Québec, Canada.
17
Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, Quebec, Canada.
18
Neurosurgery Department, Johns Hopkins School of Medicine, Baltimore, MD, USA.
19
Apeiron Biologics AG, Vienna, Austria.
20
Quartet Medicine, 400 Technology Square, Cambridge, MA, USA.
21
Department of Anesthesia, Harvard Medical School, Boston, MA, USA.
22
Boston Children's Hospital, Boston, MA, USA.
23
Department of Chemical Biology, Max-Planck Institute for Medical Research, Heidelberg, Germany.
24
Department of Neurobiology, Harvard Medical School, Boston, MA, USA. clifford.woolf@childrens.harvard.edu.
25
FM Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA. clifford.woolf@childrens.harvard.edu.
26
IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria. josef.penninger@imba.oeaw.ac.at.

Abstract

An Amendment to this paper has been published and can be accessed via a link at the top of the paper.

PMID:
31363232
DOI:
10.1038/s41586-019-1459-x

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center